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Abstract  
AIM: Helicobacter pylori causes gastric mucosal inflammation and immune reaction. However, the 
increase of IL-10, MMP-7, and MMP-7 levels in the serum is still controversial. The objective of this 
study was to investigate the serum levels of IL-10, MMP-7 & MMP-9 in gastritis patients with H. 
pylori infection.  
MATERIALS AND METHODS: A cross-sectional study was done on seventy gastritis patients that 
consecutive admitted to endoscopy units. The diagnosis of gastritis was made based on 
histopathology and diagnosis of H. pylori infection was based on rapid urease test. Serum samples 
were obtained to determine to circulate IL-10, MMP-7, and MMP-9 level. Univariate and bivariate 
analysis were done by SPSS version 22.  
RESULTS: Forthy percentages of the patients were infected with H. pylori. The IL-10 level was 
significantly higher in H. pylori-infected patients compared to non-infected patients. However, there 
were no differences between serum levels of MMP-7 and MMP-9 in infected and non-infected H. 
pylori patients.  
CONCLUSIONS: The immune response to H. pylori promotes systemic inflammation, which was 
reflected by the increased levels of serum IL-10. However, there were no significant differences in 
MMP-7 and MMP-9 serum levels between positive and negative infected H. pylori patients. 
 
 
 
 
Introduction 
 
Helicobacter pylori are bacteria that 
specifically infect the epithelial cells of the human 
gastric. Helicobacter pylori are found in the gastric of 
more than 50% of humans and frequently is the major 
cause of gastritis throughout the world [1].
 
The increase in cytokine production caused 
by Helicobacter pylori has been studied before, 
including the anti-inflammatory cytokine. This cytokine 
is responsible for the decrease in immune response. 
IL-10 is an anti-inflammatory cytokine that is capable 
of decreasing the inflammatory responses caused by 
H. pylori, which will cause the rise in bacterial num-
bers and the effects mediated by the epithelial cells of 
the gaster [2]. Patients with chronic gastritis caused 
by H. pylori infection often develops peptic ulcers, as 
well as gastric carcinoma and lymphoma [3].  
Matrix metalloproteinases (MMPs) are 
believed to have an essential role in the inflammation 
process and carcinogenesis, by causing degradation 
and remodelling of the extracellular matrix and basal 
membrane. MMP are secreted through 
transmembrane endoproteinases. MMP has a 
catalytic zinc domain, which is required for proteolytic 
activity. MMP are able to degrade at least one 
extracellular matrix component. MMP-7 and MMP-9 
are members of the MMP family, which increase in H. 
pylori gastritis and in early gastric carcinoma [4].
 
There have been many studies on the 
immune response based on gastric mucosal cytokine 
and MMP expression in H. pylori infection, however, 
the data on levels of anti-inflammatory cytokines and 
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MMP in the serum.  
In this study, the objective is to evaluate the 
increase of IL-10, MMP-7 and MMP-9 in patients with 
H. pylori infection without any systemic disease and 
the correlation with the histopathologic degree of 
gastritis.  
 
 
Patients and Methods 
 
Patient selection 
A cross-sectional study was done on seventy 
consecutive gastritis patients that were admitted to 
endoscopy units at Adam Malik General Hospital and 
Permata Bunda Hospital, Medan, Indonesia from 
May-October 2014. All patients gave informed 
consent and the study was approved by the local 
ethical committee. None of the patients had received 
antibiotics, bismuth compounds, H2 antagonists, 
proton pump inhibitors or immune modulating drugs 
within the last four weeks before endoscopy. Patients 
with evidence of malignancy, immunosuppression, 
metabolic disorders, or gastrointestinal haemorrhage 
and patients who had a history of gastric surgery were 
excluded [2, 5-7].
 
 
Diagnosis of gastritis 
Gastritis degree was evaluated from a biopsy 
of the mucosa of gastric antrum and body. The biopsy 
specimens were fixed in 10% formalin and embedded 
in paraffin. The samples were stained using 
Hematoxylin-Eosin and were evaluated by the 
pathologist of anatomic pathology referring to the 
visual analogue scale of the updated Sydney System. 
The higher degree was used if differences of degree 
were found between the body and antrum. The 
degree of chronic inflammation, neutrophil infiltration, 
atrophy, and intestinal metaplasia were scored 0 to 3, 
i.e., normal (0), mild (1), moderate (2), and severe (3) 
[5].
 
 
 
 Diagnosis of Helicobacter pylori  
H. pylori were considered positive based on 
the positive results of the rapid urease test. In this 
study, we used Pronto Dry
®
. We used gastric antral 
biopsy specimen that was taken within 2 cm from the 
pylorus for Pronto Dry
®
. The results of the rapid 
urease test were read within 24 hours. The Pronto 
Dry
® 
was considered to be positive if the colour 
changed from amber to pink-red [6]. 
 
Serum levels of IL-10, MMP-7, and MMP-9 
Venous blood was drawn using a serum 
separator tube and allowed to clot for 30-45 minutes 
at room temperature before centrifugation for 15 
minutes at approximately 1,000g. Serum was 
immediately stored frozen in aliquots at -20
o
C until 
assays for IL-10, MMP-7, and MMP-9 were 
performed. IL-10 was assayed by the high sensitive 
EBioscience technique, Bender MedSystems GmbH 
1030 Vienna, Austria. Circulating MMP-7 and MMP-9 
levels were examined in serum using the Quantikine 
Human MMP-7-ELISA and Quantikine Human MMP-
9-ELISA (Quantikine, R&D System, Inc., Minneapolis). 
Serum levels were expressed as pg/ml. Levels above 
the mean were categorised as the high level, and 
levels below the mean were categorised as the low 
level.  
 
Statistical analysis 
SPSS version 22 (SPSS Inc., Chicago) was 
used for analysis. The data were analysed using 
univariate and bivariate analysis with 95% confidence 
intervals. The results were expressed as the mean + 
standard deviation. Bivariate analysis was carried out 
using the independent t-test, Mann-Whitney test, and 
Chi-square test with a p-value < 0.05 was considered 
statistically significant. 
 
 
Results 
 
Demographics of Respondents 
 There were 70 subjects, consisting of 35 
males (50%) and 35 females (50%) subjects. The 
average age of the subjects was 49.9 + 13.04 (SD) 
years. Most subjects were from the age group of 46-
60 years old. 40% patients were infected with H. 
pylori. The occupation of most of the respondents was 
housewives (38.57%). The majority of subjects had an 
overweight or underweight nutritional status (58.57%) 
(Table 1). 
Table 1: Characteristics of the subjects 
 Variables H. pylori positive H. pylori negative Frequency 
Sex 
 Males 
 Females 
 
17 (24.28%) 
11 (15.71%) 
 
18 (25.71%) 
24 (34.29%) 
 
35 (50%) 
35 (50%) 
Age (years) 
 <30 
 30-45 
 46-60 
 >60 
 
4 (5.71%) 
9 (12.86%) 
9 (12.86%) 
6 (8.57%) 
 
3 (4.29%) 
12 (17.14%) 
18 (25.71%) 
9 (12.86%) 
 
7 (10%) 
21 (30%) 
27 (38.57%) 
15 (21.43%) 
Job 
 Self employed 
 Employee 
 Farmer 
 Housewife 
 Other 
 
7 (10%) 
4 (5.71%) 
3 (4.29%) 
9 (12.86%) 
5 (7.14%) 
 
15 (21.43%) 
5 (7.14%) 
2 (2.86%) 
18 (25.71%) 
2 (2.86%) 
 
22 (31.43%) 
9 (12.85%) 
5 (7.15%) 
27 (38.57%) 
7 (10%) 
Nutritional status 
 Normal 
Underweight and 
Overweight 
 
9 (12.86%) 
19 (27.14%) 
 
 
20 (28.57%) 
22 (31.43%) 
 
29 (41.43%) 
41 (58.57%) 
Total 28 (40%) 42 (60%) 70 (100%) 
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Serum IL-10, MMP-7 and MMP-9 levels in 
Helicobacter pylori infection 
The circulatory IL-10 levels were significantly 
higher in H. pylori-infected patients compared to non-
infected H. pylori patients (p < 0.005). However, there 
were no significant differences between serum levels 
of MMP-7 and MMP-9 in both groups (Table 2).  
Table 2: Serum level of IL-10, MMP-7 & MMP-9 in HP (+) and HP 
(-) 
Serum Level (pg/ml) 
H.pylori positive 
(mean + SD) 
H.pylori negative 
(mean + SD) 
Independent t-test 
IL-10 1.62 + 1.56 1.39 + 2.32 0.043* 
MMP-7 8.69 + 6.82 8.03 + 6.20 0.886 
MMP-9 951.86 + 522.07 889.91 + 478.78 0.640 
*p < 0.05. 
 
Association serum level of IL-10, MMP-7, 
MMP-9 and degree of gastritis 
There was no correlation found between IL-10 
serum levels with the degree of chronic inflammation 
or neutrophil infiltration. There was no correlation 
found between MMP-7 serum levels with the degree 
of chronic inflammation or neutrophil infiltration. The 
same results were found for MMP-9 serum levels. 
There was no correlation found between MMP-9 
serum levels with the degree of chronic inflammation 
or neutrophil infiltration (Table 3). 
Table 3: Association serum levels of IL-10, MMP-7, MMP-9 and 
degree of chronic inflammation and neutrophil infiltration 
Cytokines 
Chronic Inflammation Neutrophil Infiltration 
Normal + 
Mild 
N (%) 
Moderate 
+ Severe 
N (%) 
OR (95% 
CI) 
P 
Normal 
+ Mild 
N (%) 
Moderate 
+ Severe 
N (%) 
OR (95% 
CI) 
p 
IL-10 High 
15 
(21.43) 
19 
(27.14) 
1.01 
(0.59-
1.70) 
0.978 
26 
(37.14) 
8 (11.43) 0.872 
(0.65-
1.17) 
0.364 
 Low 
16 
(22.86) 
20 
(28.57) 
24 
(34.29) 
12 
(17.14) 
MMP-7 High 
12 
(17.14) 
23 
(32.86) 
1.58 
(0.91-
2.75) 
0.092 
23 
(32.86) 
12 
(17.14) 
1.17 
(0.87-
1.58) 
0.290 
 Low 19(27.14) 
16 
(22.86) 
27 
(38.57) 
8 (11.43) 
MMP-9 High 14 (20) 21 (30) 1.21 
(0.72-
2.06) 
0.470 
24 
(34.29) 
11 
(15.71) 
1.08 
(0.81-
1.46) 
0.597 
 Low 
17 
(24.29) 
18 
(25.71) 
26 
(37.14) 
9 (12.86) 
 
There was no correlation found between IL-10 
serum levels with the degree of atrophy or intestinal 
metaplasia. There was no correlation found between 
MMP-7 serum levels and the degree of atrophy or 
intestinal metaplasia.  
Table 4: Association serum levels of IL-10, MMP-7, MMP-9 and 
degree of atrophy and intestinal metaplasia 
Cytokines 
 
Atrophy Intestinal Metaplasia 
Normal + 
Mild 
N (%) 
Moderate 
+ Severe 
N (%) 
OR (95% 
CI) 
P 
Normal 
+ Mild 
N (%) 
Moderate 
+ Severe 
N (%) 
OR 
(95% CI) 
p 
IL-10 High 
27 
(38.57) 
7 (10) 1.13 
(0.88-
1.45) 
0.318 
25 
(35.71) 
9 (12.86) 
1.12 (0.91-
1.38) 
0.276 
 Low 
32 
(45.71) 
4 (5.71) 
30 
(42.86) 
6 (8.57) 
MMP-7 High 
30 
(42.85) 
5 
(7.14) 
0.83 
(0.65-
1.07) 
0.145 
30 
(42.86) 
5 (7.14) 
0.97 (0.79-
1.18) 
0.743 
 Low 
25 
(35.71) 
10 
(14.28) 
29 
(41.43) 
6 (8.57) 
MMP-9 High 
29 
(41.43%) 
6 
(8.57%) 
1.04 
(0.810-
1.33) 
0.771 
27 
(38.57) 
8 
(11.43) 1.03 (0.85-
1.27) 
0.743 
 Low 
30 
(42.85) 
5 
(7.14) 
28 (40) 7 (10) 
 
The same results were found for MMP-9 
serum levels. There was no correlation found between 
MMP-9 serum levels and the degree of atrophy or 
intestinal metaplasia (Table 4). 
 
 
Discussion 
 
The average age of the subjects was 49.9 + 
13.04 (SD) years, which concludes that most of the 
gastritis patients are at their productive ages. The 
results of this study are similar to a study conducted 
by Garg B, et al, which reported that the average age 
of gastritis patients was 47 years old and the study 
reported by Mustapha SK, et al with an average age 
of 47 years old [7, 8].
 
In this study, a group of gastritis patients 
without major gastric disease (example: peptic ulcer 
and gastric carcinoma) were studied with the objective 
to examine the presence of H. pylori infection in 
gastritis patients. It is known that H. pylori are 
correlated with increased expressions of IL-10, MMP-
7, and MMP-9 in the mucosa [9-12]. 
However, studies on the levels of IL-10, MMP-
7 and MMP-9 in the serum are still limited and 
controversial. Owing to that, this study was conducted 
with the objective to find the differences between the 
serum levels of IL-10, MMP-7 and MMP-9 in patients 
with positive and negative H. pylori, and to analyse 
the correlations between the serum levels and the 
degree of gastritis based on histopathology 
appearance.  
IL-10 as an anti-inflammatory cytokine has a 
role in the initial immune response which is mediated 
by B cell. Cytokine IL-10 is involved in the decrease of 
the inflammatory response [13]. IL-10 inhibits the 
synthesis of IFN-c, IL-1, IL-6, IL-8 and TNF-α, and 
also acts as a feedback mechanism in reducing these 
cytokines [13, 14]. IL-10 might contribute to the failure 
of the immune response to clear H. pylori infection, 
and in a previous study we found the increased 
secretion of IL-10 in biopsy specimens in H. pylori 
infection, with the secretion of the cytokine correlating 
with the degree of chronic inflammation. Yamaoka et 
al have reported increased expression of IL-10 mRNA 
in biopsies from infected patients [15]. 
IL-10 helps to maintain bacterial colonisation 
and exerts its effects directly on gastric epithelial cells 
[2, 10, 11].
 
Goll et al reported that samples from H. 
pylori-positive patients showed increased production 
of IL-10 as much as 6.7 times the production of 
patients with negative H. pylori. 
In this study, the serum levels of IL-10 
increased significantly in positive H. pylori compared 
to negative H. pylori patients. This result was similar 
to that reported by Dlugovittzky et al, where the IL-10 
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serum levels of the positive H. pylori subjects were 
higher compared to negative H. pylori subjects 
(p<0.01) [16]. However, other studies reported 
different conclusions, In the studies performed by 
Russo et al and Bayraktaroglu et al, they reported that 
there were no significant correlations between the 
positive H. pylori subjects and negative subjects, 
which might be caused by inhibition of further 
inflammation [17, 18]. 
H. pylori is able to trigger the expression of 
MMP, which is a proteolytic enzyme that has a role in 
maintaining and remodelling the interaction between 
epithelial cells and the basal membrane [19, 20]. A 
study, conducted by Bebb JR et al, found that gastric 
biopsy specimens from a positive H. pylori subject will 
show in a higher level of MMP-7 protein in the antrum 
and corpus [19]. A similar result is found from the 
study conducted by Wroblewski et al, which 
concluded that the MMP-7 expression in the antrum 
and corpus increased with the presence of H. pylori 
[21].
 
In this study, there were no significant 
differences in MMP-7 serum levels between positive 
and negative H. pylori subjects. The same results 
were found in the study by Rautelin et al, which 
concluded that there were no significant differences in 
MMP-7 serum levels between positive and negative 
H. pylori gastritis subjects [22].
 
Studies by Rautelin HI et al and Li SL et al 
found that MMP-9 level increased significantly in the 
gastric mucosa of gastritis patients with positive H. 
pylori compared to the negative [22, 23]. In a study 
conducted by Oliviera, it was found that H. pylori 
through a T4SS (Type IV Secretion System) pathway 
increases the activity of MMP-9 as a response to the 
invasion of H. pylori on the gastric epithelium [24]. 
In this study, there was no difference in the 
serum levels of MMP-9 between the positive and 
negative H. pylori patients. Similar results were also 
found in the study reported by Rautelin et al and 
Ettehad et al, where it was concluded that there were 
no significant differences in the MMP-9 levels of the 
gastritis patients between the positive and negative H. 
pylori subjects [25, 26]. 
In this study, it was found that there were no 
significant correlations found between serum levels of 
IL-10, MMP-7, MMP-9 and the degree of chronic 
inflammation, neutrophil infiltration, atrophy, or 
intestinal metaplasia (p>0.05). 
 In conclusion, the IL-10 serum levels 
increased significantly in positive H. pylori subjects. 
There was no significant difference in the average 
serum levels of MMP-7 and MMP-9 between positive 
and negative infected H. pylori patients. There were 
no correlations found between serum levels of IL-10, 
MMP-7, MMP-9 with the degree of gastritis based on 
histopathology.  
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